Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 May-Jun;9(4):381-386.
Epub 2018 May 1.

Feasibility of Outpatient High-Dose Methotrexate Infusions in Pediatric Patients With B-Lineage Acute Lymphoblastic Leukemia

Affiliations
Review

Feasibility of Outpatient High-Dose Methotrexate Infusions in Pediatric Patients With B-Lineage Acute Lymphoblastic Leukemia

Joy L Bartholomew et al. J Adv Pract Oncol. 2018 May-Jun.

Abstract

High-dose methotrexate (MTX) given in four hospitalizations during interim maintenance for high-risk pediatric B-lineage acute lymphocytic leukemia significantly improves survival but increases resource utilization. Children remain hospitalized for intravenous hydration and blood or urine monitoring until MTX clearance parameters are reached. Improved supportive care, extended infusion center hours, and pediatric home health expertise afford alternatives to prolonged hospital admissions, potentially offering quality, cost-effective approaches that positively impact the delivery of care.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study design.
Figure 2
Figure 2
Paired profiles for antiemetic use.
Table 1
Table 1
Inpatient Compared to Outpatient Infusions

References

    1. American Cancer Society. Economic impact of cancer. 2018 Retrieved from https://www.cancer.org/cancer/cancer-basics/economic-impact-of-cancer.html.
    1. Hunger Stephen P, Loh Mignon L, Whitlock James A, Winick Naomi J, Carroll William L, Devidas Meenakshi, Raetz Elizabeth A. Children’s Oncology Group’s 2013 blueprint for research: acute lymphoblastic leukemia. Pediatric blood & cancer. 2013;60:957–963. - PMC - PubMed
    1. Larsen E C, Salzer W L, Devidas M, Nachman J B, Raetz E A, Loh M L, Carroll W L. Comparison of high-dose methotrexate (HD-MTX) with Capizzi methotrexate plus asparaginase (C-MTX/ASNase) in children and young adults with high-risk acute lymphoblastic leukemia (HR-ALL): A report from the Children’s Oncology Group Study AALL0232 [Abstract 3]. Journal of Clinical Oncology. 2011;29(15_suppl)
    1. Lippert M, Semmens S, Tacey L, Rent T, Defoe K, Bucsis M, Shykula T, Crysdale J, Lewis V, Strother D, Lafay-Cousin L. The Hospital at Home program: no place like home. Current oncology (Toronto, Ont.) 2017;24:23–27. - PMC - PubMed
    1. Mahadeo Kris M, Santizo Ruth, Baker Lindsay, Curry Joan O'Hanlon, Gorlick Richard, Levy Adam S. Ambulatory high-dose methotrexate administration among pediatric osteosarcoma patients in an urban, underserved setting is feasible, safe, and cost-effective. Pediatric blood & cancer. 2010;55:1296–1299. - PubMed

LinkOut - more resources